- Home
- ONCO vs KUST Comparison
ONCO vs KUST Comparison
Compare ONCO & KUST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.48
N/A
Current Price
$2.14
Company Overview
Basic Information| Metric | ONCO | KUST |
|---|---|---|
| Founded | 2018 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3M | 4.6M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | ONCO | KUST |
|---|---|---|
| Price | $1.48 | $2.14 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 142.2K | ★ 6.2M |
| Earning Date | 11-13-2025 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,223,751.00 | ★ $19,097,965.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.38 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.37 | $1.81 |
| 52 Week High | $88.40 | $2,500.80 |
Technical Indicators
Market Signals| Indicator | ONCO | KUST |
|---|---|---|
| Relative Strength Index (RSI) | 35.31 | N/A |
| Support Level | $1.51 | N/A |
| Resistance Level | $2.30 | N/A |
| Average True Range (ATR) | 0.21 | 0.00 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
Price Performance
Historical Comparison ONCO
KUST
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.